Results 241 to 250 of about 17,462,775 (406)

Blood Cell

open access: yesIUPAC Standards Online, 2019
J. Labuda   +16 more
semanticscholar   +1 more source

Germline variants in CDKN2A wild‐type melanoma prone families

open access: yesMolecular Oncology, EarlyView.
Among melanoma‐prone families, wild‐type for CDKN2A and CDK4, some have pathogenic variants in genes not usually linked to melanoma. Furthermore, rare XP‐related variants and variants in MC1R are enriched in such families. Germline pathogenic variants in CDKN2A are well established as an underlying cause of familial malignant melanoma. While pathogenic
Gjertrud T. Iversen   +5 more
wiley   +1 more source

Multiscale deformed attention networks for white blood cell detection. [PDF]

open access: yesSci Rep
Zheng X   +5 more
europepmc   +1 more source

Blood-volume measurements in cancer using the Cr51 red-blood-cell tagging method [PDF]

open access: bronze, 1956
William A. Reilly   +2 more
openalex   +1 more source

Resistance to malaria through structural variation of red blood cell invasion receptors

open access: yesScience, 2016
E. Leffler   +39 more
semanticscholar   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

open access: yesMolecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit   +19 more
wiley   +1 more source

Reduced Red Blood Cell Deformability in Vivax Malaria. [PDF]

open access: yesJ Infect Dis
Rathnam JTT   +8 more
europepmc   +1 more source

Time, the final frontier

open access: yesMolecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain   +3 more
wiley   +1 more source

Red blood cell-tumor cell interactions promote tumor cell progression. [PDF]

open access: yesJ Exp Clin Cancer Res
Pereira-Veiga T   +37 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy